Introduction about drugs essay

It is theorized that replacement of vital thymus peptides can replace those missing due to atrophy of the thymus brought on by the aging process in much the same way diabetics use insulin. The technology now exists to produce these proteins in their natural intact state. Reintroduction of them in adult humans could have a profound effect on the aging process by restoring the bodies natural ability to defend itself from disease. the thymus gland produces dozens of these proteins and each one may have a specific purpose in human health and aging.

  • One particularly exciting development has been the use of learning systems to discover new drugs. The learning system is given examples of one or more drugs that weakly exhibit a particular activity, and based upon a description of the chemical structure of those compounds, the learning system suggests which of the chemical attributes are necessary for that pharmacological activity. Based upon the new characterisation of chemical structure produced by the learning system, drug designers can try to design a new compound that has those characteristics. Currently, drug designers synthesis a number of analogues of the drug they wish to improve upon, and experiment with these to determine which exhibits the desired activity. By boot-strapping the process using the machine learning approach, the development of new drugs can be speeded up, and the costs significantly reduced. At present statistical analyses of activity are used to assist with analogue development, and machine learning techniques have been shown to at least equal if not outperform them, as well as having the benefit of generating knowledge in a form that is more easily understood by chemists (King et al., 1992). Since such learning experiments are still in their infancy, significant developments can be expected here in the next few years.
  • Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry is a dynamic conference for medicinal chemists working in pharma and biotech. Focused on discovery and optimization challenges of small molecule drug candidates, this event provides many exciting opportunities for scientists to create a unique program to hear presentations most suited to one's personal interests by going back and forth among concurrent meeting tracks.

    New for 2018 is expanded coverage of Small Molecules for Cancer Immunotherapy, plus new coverage of Ubiquitin Proteasome System Inhibitors, Targeting Complex Membrane Proteins, as well as Lead Optimization for Drug Safety.

    While most speakers will be invited, if you would like to be considered for a podium presentation, please submit a speaker proposal by September 22 for priority consideration.

    Introduction about drugs essay

    introduction about drugs essay


    introduction about drugs essayintroduction about drugs essayintroduction about drugs essayintroduction about drugs essay